Gf Fund Management Co. Ltd. Adagio Therapeutics, Inc. Transaction History
Gf Fund Management Co. Ltd.
- $5.85 Trillion
- Q4 2025
A detailed history of Gf Fund Management Co. Ltd. transactions in Adagio Therapeutics, Inc. stock. As of the latest transaction made, Gf Fund Management Co. Ltd. holds 5,446 shares of ADGI stock, worth $18,026. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,446Holding current value
$18,026% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ADGI
# of Institutions
86Shares Held
153MCall Options Held
244KPut Options Held
167K-
Janus Henderson Group PLC London, X025.4MShares$84 Million0.04% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct20.3MShares$67.2 Million0.13% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx19MShares$62.8 Million0.93% of portfolio
-
Ra Capital Management, L.P. Boston, MA17.1MShares$56.7 Million0.97% of portfolio
-
Mithril Ii Gp LP Austin, TX11.2MShares$37.2 Million19.18% of portfolio
About Adagio Therapeutics, Inc.
- Ticker ADGI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 108,831,000
- Market Cap $505M
- Description
- Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. The company's lead product candidate is the ADG20 (adintrevimab), a neutralizing antibody that is in Phase 3 clinical trials for the treatmen...